$TER

MATZ MARILYN sold $508K of TER

MATZ MARILYN sold 1,200 shares of TERADYNE, INC (TER) at $423.03 ($0.51M total) on 2026-06-15 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · MATZ MARILYN
Published Jun 16, 2026, 10:01 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 16, 2026, 10:06 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$TER
Neutral
high confidence
Mentioned
$TER
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TERNeutralLow
01

Why it matters

A director’s open-market sale under a pre-arranged 10b5-1 plan is typically treated as non-informational; the main trading relevance is sentiment/positioning rather than fundamentals.

02

Market read

Traders may note the insider sale for sentiment, but there is no new guidance, deal, or operational catalyst in the text.

03

What to watch

The article provides only one director sale size and does not indicate whether other insiders are buying/selling around the same window.

Relevance 4/10Novelty 6/10Timing: Filed 2026-06-16; transaction dated 2026-06-15

Background

The article is a SEC Form 4 insider transaction disclosure for Teradyne, Inc.

Company-level read

Ticker impact

$TERNeutralHigh confidence
Context

Teradyne director Marilyn Matz sold 1,200 shares at $423.03 via an open-market transaction under a pre-arranged 10b5-1 plan.

Expected impact

Low likelihood of a sustained price move solely from this Form 4; any impact would be short-lived.

Evidence & confidence

The filing is an insider sale (not a buy), explicitly under a pre-arranged 10b5-1 plan, with no accompanying operational or guidance change disclosed.

Market effects

No sector read-across; this is company-specific insider transaction disclosure.

None indicated.

None indicated.

Counterpoint

Even with 10b5-1, repeated insider selling can coincide with internal caution; traders may still fade rallies if other selling emerges.

Key entities

  • TERADYNE, INC

    US-listed company whose director insider sale is disclosed on Form 4.

  • MATZ MARILYN

    Director who sold 1,200 shares of TER under a pre-arranged 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$FORMHighAI 8/10

FormFactor and Teradyne announce collaboration, $300M investment

FormFactor (FORM) and Teradyne (TER) announced a collaboration and $300M investment in semiconductor test and measurement technologies. The deal aims to combine FormFactor's probe technologies with Teradyne's automated test platforms, focusing on high-performance compute and advanced packaging applications. The transaction is subject to regulatory approvals.